Objective-Extensive remodeling of the valve ECM in calcific aortic valve sclerosis alters its mechanical properties, but little is known about the impact of matrix mechanics on the cells within the valve interstitium. In this study, the influence of matrix stiffness in modulating calcification by valve interstitial cells (VICs), and their differentiation to pathological phenotypes was assessed. Methods and Results-Primary porcine aortic VICs were cultured in standard media or calcifying media on constrained type I fibrillar collagen gels. Matrix stiffness was altered by changing only the thickness of the gels. Calcification did not occur in standard media, regardless of matrix stiffness. However, when VICs were grown in calcifying media on relatively compliant matrices with stiffness similar to that of normal tissue, they readily formed calcified aggregates of viable cells that expressed osteoblast-related transcripts and proteins. In contrast, VICs cultured in calcifying media on stiffer matrices (similar to stenotic tissue) differentiated to myofibroblasts and formed calcified aggregates that contained apoptotic cells. Actin depolymerization reduced aggregation on stiff, but not compliant, matrices. TGF-␤1 potentiated aggregate formation on stiff matrices by enhancing ␣-smooth muscle actin expression and cellular contractility, but not on compliant matrices attributable to downregulation of TGF-␤ receptor I. Cell contraction by VICs inhibited Akt activation and enhanced apoptosis-dependent calcification on stiff matrices.
D ysregulation of normal cellular processes 1,2 leads to aortic valve sclerosis (AS), a common disease 3 that involves chronic inflammation, fibrosis, and calcification. 4, 5 The consequences of AS are serious, as even minor valve calcification increases the risk of other cardiovascular disorders by 50%, and the prognosis with progression to sclerosis is poor. 6 Treatment is limited to surgical replacement of the stenotic valves, as effective medical therapies do not exist.
The progression of sclerosis and calcification is mediated primarily by valve interstitial cells (VICs) that populate the interstitial matrix. 1, 7 As in the vasculature, 8 calcification of the aortic valve occurs through multiple mechanisms, 9 including apoptosis-related calcification typically associated with myofibrogenic activation of VICs, 10, 11 calcium deposition associated with necrotic cells, 12 and bone formation by resident VICs 13 or bone marrow-derived cells. 10 However, details of the cellular mechanisms by which VICs contribute to calcification are not well understood, largely because of the limited number of studies in vitro and difficulties with their interpretation. For example, when VICs are induced to form calcified multicellular aggregates in vitro, the aggregates are associated with the expression of bone-related transcripts and proteins, the expression of myofibroblast markers, or apoptosis. 7,14 -17 It is unclear whether these features represent a single or multiple calcification process(es).
The factors that contribute to the dysregulation of VICs leading to calcification are also not fully defined. While a variety of biochemical cues, including transforming growth factor (TGF)-␤, have been implicated in valve calcification, 5 mechanical cues from the extracellular matrix may also regulate cell function, both in vivo and in vitro. Notably, cells are able to "sense" the local mechanical properties of their extracellular matrix, and matrix stiffness is known to regulate motility, proliferation, and differentiation in various cell types. 18 The differentiation of VICs to myofibroblasts was recently shown to be influenced by matrix stiffness, 19 but the role of matrix mechanics in regulating calcification by VICs has yet to be determined. An improved understanding of VIC-matrix interactions is required to aid in interpretation of VIC calcification studies in vitro; to guide the selection of biomaterials with appropriate mechanical properties for valve tissue engineering; and to assess whether alterations in extracellular matrix mechanics that occur with disease 20,21 modulate pathological changes in VIC phenotypes and calcification processes.
To gain a better understanding of calcification by VICs and its regulation by mechanical cues, we studied the influence of matrix stiffness on primary porcine aortic VICs in vitro using a fibrillar collagen-based system with tunable substrate stiffness. We found that the response of VICs to procalcific soluble factors is sensitive to matrix stiffness. VICs grown in procalcific conditions preferentially differentiate to osteoblast-like cells on compliant substrates that mimic the stiffness of normal or early sclerotic tissue, but differentiate to myofibroblasts on stiffer substrates that mimic the stiffness of stenotic tissue. Calcified aggregates form in both cases, but through distinct processes that are differentially mediated by cytoskeletal tension.
Methods

Valve Interstitial Cell Culture
Primary porcine aortic VICs were isolated by collagenase digestion. Constrained compliant and stiff collagen matrices were constructed following procedures described previously. 22 The stiffness was controlled by changing only the thickness of the matrices, which were otherwise formed identically. VICs were seeded on collagen matrices in either DMEM with 10% fetal bovine serum (FBS), or in calcifying medium consisting of complete medium supplemented with 10 mmol/L ␤-glycerophosphate, 10 g/mL ascorbic acid and 10 nmol/L dexamathesone.
Characterization of Collagen Content and Mechanical Properties of Collagen Matrices
Collagen content and the effective stiffness of the compliant and stiff matrices throughout the culture period were measured by the hydroxyproline assay and compression testing, respectively. The effective stiffness of the matrices was also estimated under shear loading by finite element analysis (please see the supplemental materials, available online at http://atvb.ahajournals.org).
Cellular Proliferation and Viability
Proliferation of VICs was determined based on measurement of DNA content. Cell viability was determined by fluorescent labeling of live cells with calcein AM and of dead cells with ethidium homodimer-1 (EthD-1). Apoptotic cells were identified by cellular uptake of APOPercentage dye (Biocolor Ltd).
Osteoblast-Related Biomarkers
Transcriptional expression of osteonectin and osteocalcin were quantified by real-time PCR. The amount of the bone transcription factor runt-related transcription factor 2 (Runx2) was measured in VIC nuclear extracts using an ELISA-based immunoassay (TransAM kit, ActiveMotif) and normalized by total cell number. Alkaline phosphatase (ALP) activity was detected by biochemical staining. Osteocalcin was detected by immunohistochemical staining. VIC cultures were stained with Alizarin red S (ARS) solution for calcium deposition. Calcium content was quantified by measuring the absorbance of ARS dye released from the stained culture. 23
Immunofluorescent Staining of Cytoskeletal Proteins
VICs were fixed and permeablized for costaining with monoclonal mouse anti-␣-smooth muscle actin antibody (␣-SMA) and fluoroscein isothiocyanate (FITC)-conjugated Phalloidin for F-actin followed by nuclear counterstain with Hoechst 33242 dye.
Disruption of Cytoskeleton Assembly and TGF-␤1 Response
VICs were cultured on compliant or stiff matrices with calcifying media for 6 days, at which point aggregation had not occurred on either matrix. VICs were then treated with 0.4 nmol/L swinholide A (SWA) for 2 days to disrupt the assembly of actin. In a separate set of experiments, VICs were cultured on compliant and stiff matrices and were treated immediately with calcifying media (containing 10% FBS) and 5 ng/mL of TGF-␤1 for 5 days to induce ␣-SMA-dependent aggregate formation.
Secreted TGF-␤1 and TGF-␤1 Receptor Expression
The total amount of TGF-␤1 in supernatant collected from cultured cells was measured and normalized to total cell number. Transcriptional expression of TGF-␤1 receptor I and receptor II were estimated by RT-PCR.
Contraction-Dependent Apoptosis and Akt Activation
A stress-relaxation collagen gel model 24 was used to evaluate the relationship between cell contraction, apoptosis, and Akt activity. Briefly, VICs were cultured on the surface of constrained collagen gels for 6 days, at which point the gels were released. Apoptosis was measured immediately as well as 0.5 hours and 3 hours after gel release. Total and phosphorylated Akt were detected in cell lysates before and 1 hour after gel release by Western blotting.
Statistical Analysis
Results are presented as meanϮSE. Unpaired Student t test or ANOVA and Fisher least significant difference test were used as appropriate.
Results
Characterization of Collagen Matrices
Cells were cultured on constrained fibrillar collagen matrices. Thick (Ϸ2.5 mm thickness) and thin (Ϸ10 m thickness) matrices had uniform fibrillar collagen microstructure (supplemental Figure IA and IB), with similar collagen fiber diameters (Pϭ0.27, supplemental Figure IC ). Because of the differences in the gel thickness alone, the thick matrices were significantly more compliant than the thin matrices in compression (PϽ0.05, supplemental Figure ID ) and shear (refer to supplemental methods). Despite degradation of the compliant matrices over the culture period, which reduced the overall thickness of these matrices to approximately 1.75 mm, the stiffness of both the thick and thin matrices remained constant (supplemental Figure II ).
Proliferation and Morphological Changes
When cultured in complete medium without calcifying supplements, VICs proliferated more rapidly on compliant matrices (PϽ0.05; supplemental Figure IIIA ), but the morphology was similar on the two matrices ( Figure 1A and 1B). In contrast, VIC proliferation rate was not significantly different on stiff and compliant matrices when cultured in calcifying media (supplemental Figure IIIB) , but morphological differences were substantial. In calcifying media, VICs on compliant matrices formed multicellular aggregates after 8 to 10 days of culture ( Figure 1C ). In contrast, VICs on stiff matrices formed fewer aggregates (PϽ0.05) and instead tended to form ridges ( Figure 1D and 1E ). In medium without procalcific supplements, there was no aggregation on either substrate over the culture period.
More Compliant Matrices Promote Osteogenic Differentiation of VICs
VICs can form aggregates in vitro that contain calcium deposits and osteoblast-related proteins, 7 so we investigated whether this was the case for the cell aggregates on compliant and stiff collagen matrices. There was a trend for greater calcification on the compliant matrices (PϽ0.06; Figure 2A ). Calcium deposition was localized within the aggregates formed on both matrices (supplemental Figure IV) . Transcriptional expression of osteonectin and osteocalcin were significantly higher in VICs cultured on compliant matrices (PϽ0.05 for osteonectin; PϽ0.06 for osteocalcin; Figure 2B ), as were protein expression of Runx2 (PϽ0.05; Figure 2C ), ALP activity ( Figure 2D ), and osteocalcin protein expression ( Figure 2F ). ALP activity and osteocalcin expression were localized within the aggregates on compliant matrices. On stiff substrates, ALP activity was weak and dispersed throughout the cell layer ( Figure 2E ) and minimal osteocalcin expression was observed, even in aggregates ( Figure 2G ).
Stiffer Matrices Promote Calcification Through Apoptosis
Although VICs on stiff matrices expressed osteoblast-related markers at low levels, significant calcium deposition was observed within the few aggregates that formed. Morphological analysis by SEM revealed significant differences in the spreading and shape of the cells on the surface of and around the multicellular aggregates on the 2 matrices ( Figure 3A and 3B), which suggested that the aggregates formed and calcified through different mechanisms on the 2 matrices. Both in vivo and in vitro, calcification can occur through a process involving apoptosis, 11, 15 so we examined cell viability in the aggregates. On compliant matrices, the aggregates contained viable cells with little evidence of apoptosis ( Figure 3C and 3E). Positive calcein AM staining was not attributable to the presence of calcium, as formalin-fixed calcified aggregates stained negatively ( Figure 3C , inset). In contrast, aggregates formed on stiff matrices contained dead and apoptotic cells ( Figure 3D and 3F ).
Aggregate Formation on Stiffer Matrices Is Mediated by Cytoskeletal Tension
The striking differences in VIC phenotypes, aggregate morphology, and calcification process on compliant versus stiff matrices in otherwise identical culture conditions suggested that VICs sense and respond to matrix stiffness. Stiff culture surfaces, such as tissue culture polystyrene, are known to promote myofibrogenic differentiation of VICs and increase expression of filamentous ␣-SMA, 19 a cytoskeletal protein that contributes to the contractility of activated VICs. We found that VICs displayed F-actin fibers regardless of matrix stiffness (supplemental Figure V) . However, VICs on compliant matrices expressed predominantly monomeric ␣-SMA, whereas abundant expression of filamentous ␣-SMA was observed only in cells cultured on stiff matrices ( Figure 4A and 4B) consistent with the emergence of a myofibroblast phenotype. We investigated the role of actin assembly in matrix stiffness-dependent aggregate formation by disrupting actin filaments in VICs. Actin depolymerization was observed in VICs after 48 hours of SWA treatment on both matrices ( Figure 4C and 4D ). Cells remained attached to the matrices; some were rounded with limited extension of cytoplasmic processes ( Figure 4G and 4H ). On compliant matrices, actin disruption had no effect on the formation of cell aggregates that displayed osteogenic phenotypes ( Figure  4G ). In contrast, on stiff matrices disruption of actin assembly significantly reduced the formation of aggregates (PϽ0.05; Figure 4H and 4I). These data, along with the "contracted" appearance of the aggregates formed on the stiff matrices ( Figure 3B ), suggested that apoptosis leading to calcification on stiff substrates may be attrituable to local contraction of the cell layer resulting from increased cytoskeletal tension, which is then released on aggregation. To test this, we released constrained collagen gels seeded with VICs and observed a significant increase in the number of apoptotic cells ( Figure  5A ). Previous studies have identified the Akt signaling pathway as the mediator of contraction-dependent apoptosis. 25 We found that Akt activation was downregulated on gel contraction by VICs ( Figure 5B ), before apoptosis, suggesting mechanically-regulated Akt activity influences apoptosis in VICs.
VIC Response to TGF-␤ and the Expression of its Receptors Are Matrix Stiffness-Dependent
TGF-␤1 is a potent inducer of ␣-SMA expression and myofibroblast differentiation. It is also expressed in calcified aortic valves 15 and promotes VIC apoptosis and calcified aggregate formation in vitro. 7, 15 We evaluated whether matrix stiffnessdependent aggregation was influenced by TGF-␤1. No differences were detected in endogenous total TGF-␤1 production by VICs on compliant versus stiff matrices (data not shown). After only 5 days of culture, aggregates formed on stiff matrices treated with 5 ng/mL exogenous TGF-␤1 (28Ϯ4 aggregates), but not without TGF-␤1 (zero aggregates; PϽ0.05). In contrast, no aggregates were observed after 5 days on compliant matrices in the absence or presence of TGF-␤1. VICs grown in calcifying media for 8 days on either substrate had significantly lower expression of both TGF-␤1 receptor I and II compared with freshly isolated VICs (PϽ0.05; supplemental Figure VI) . Whereas TGF-␤ receptor II expression was not different on compliant versus stiff matrices, TGF-␤ receptor I expression was significantly lower in VICs on compliant matrices (PϽ0.05; supplemental Figure VI) . These data suggest that the preferential responsiveness to TGF-␤1 on stiff matrices is mediated in part through matrix stiffness-dependent expression of TGF-␤ receptor I.
Discussion
VICs, 7 vascular smooth muscle cells, 26 and pericytes 27 can be induced in vitro to form aggregates that are typically referred to as calcified nodules. The mechanisms by which VICs form calcified aggregates and the factors that regulate these processes are not well defined. Here, we demonstrated 2 distinct calcification processes that are mechanically regulated and associated with different cell phenotypes. VICs cultured in calcifying media on more compliant matrices were viable, acquired osteoblast-like properties, and formed calcified bone-like nodules. In contrast, VICs cultured in the same media but on the stiffer matrices had minimal osteoblast marker expression, differentiated to contractile myofibroblasts, and formed calcified aggregates containing apoptotic cells. Importantly, calcification on either matrix occurred within the culture duration only when the VICs were exposed to calcifying medium. Thus, matrix stiffness alone was insufficient to cause calcification but worked in conjunction with soluble factors to regulate VIC differentiation and calcification.
The experimental system used here permitted specific investigation of distinct calcification mechanisms; this has not been possible to date and has been largely ignored, confounding interpretation of cell culture data and limiting our understanding of the mechanisms underlying calcification by VICs. We used primary VICs to capture the heterogeneity of VICs in intact valves 2,28 and to avoid the phenotypic changes that occur with subculture, including myofibroblast differentiation 19 and loss of osteoprogenitors. 29 Cells were grown on fibrillar type I collagen gels instead of monomeric collagen-coated synthetic gels 30 to better mimic the native ECM in heart valves. This may be important as different intracellular signaling pathways are activated when cells bind fibrillar versus monomeric collagen. 31, 32 Although the compliant and stiff matrices were biochemically identical initially, changes in matrix composition attributable to cell remodeling may have occurred with time in culture. Calcification by valvular and vascular cells is similar on collagen-and fibronectin-coated substrates, 33, 34 suggesting that replacement of collagen with fibronectin during remodeling would not elicit the differences observed in the current study. The effect of other matrix components produced by VICs on calcification is unknown, and thus characterization of the compositional changes that occur in the gels because of remodeling would better define the relative contributions of matrix stiffness versus composition. To manipulate only matrix stiffness, we were limited to a 2D system, as decoupling of matrix mechanics and chemistry is not possible with 3D fibrillar collagen matrices. 30 Based on previous studies, 35, 36 some VIC responses are similar in 3D matrices as on 2D surfaces, but 3D matrix stiffness effects on VIC differentiation have yet to be studied.
Based on Hertz contact analysis of microindentation data of collagen gels identical to those used here, 37 the apparent elastic moduli of the thick and thin collagen matrices are estimated to be 27 kPa and 113 kPa, respectively. Of note, VICs underwent osteogenic differentiation in the same stiffness range (25 to 40 kPa) as bone marrow-derived MSCs, 38 consistent with recent evidence that the aortic valve also contains a subpopulation of MSCs with robust osteogenic calcification potential. 29 The differentiation of VICs to contractile myofibroblasts that express filamentous ␣-SMA on stiff substrates has been reported previously. 19 The primary inducers of myofibroblast differentiation are mechanical tension and TGF-␤. 39 Cytoskeletal tension is generated intrinsically by cells as they exert tractional forces on the surrounding extracellular matrix; stiff matrices provide greater resistance to deformation, resulting in greater tractional forces. 18 The incorporation of ␣-SMA into stress fibers aids in force generation. 40 We found that ␣-SMA stress fibers were critical to aggregation on stiffer matrices, as this process was inhibited by treatment with SWA, which disrupts polymerization of ␣-SMA, 41 and was promoted by TGF-␤1. The dependency of aggregation on cytoskeletal tension, along with the appearance of ridges and the final symmetrical morphology of the aggregates suggested that the aggregates formed by local contraction of the cell layer. Release of mechanical tension in VICs, as would occur with contraction-induced aggregation, reduced Akt activity and subsequently triggered apoptosis as it does in other myofibroblasts. 24, 25, 42 Apoptosis is associated with calcification of vascular and valvular cells in vitro 43 and in vivo, 11, 44 and is required for TGF-␤1-induced calcification by VICs. 15 Our observations suggest a mechanically-based mechanism with which to interpret in vitro models of apoptosis-associated VIC calcification, particularly those performed on stiff polystyrene tissue culture plates that induce myofibroblast differentiation. 19 This mechanism is also likely to be important in vivo where increases in myofibroblasts, 19, 45 apoptotic cells, 11 and TGF-␤ 15 are observed in sclerotic leaflets and alterations in matrix tension are believed to be a trigger for myofibroblast apoptosis during wound repair. 24, 42 In contrast to stiff matrices, addition of exogenous TGF-␤1 did not accelerate calcification on compliant substrates. The relative insensitivity of the cells on the compliant matrices to TGF-␤1 likely resulted from lower expression of the TGF-␤ receptor I. Fibroblasts are less sensitive to TGF-␤ when grown in 3D spheroids than when grown as 2D monolayers on glass. 46 The differential responsiveness was reported to correlate with downregulation of TGF-␤ receptor expression in 3D culture, which in light of our findings, may reflect differences in effective matrix mechanical properties between 2D and 3D culture systems. We also observed significant downregulation of both TGF-␤ receptor I and II transcripts in VICs grown under calcifying conditions on either substrate compared to those freshly isolated from normal valves. This is consistent with observations from explanted human aortic valves, in which these receptors were downregulated in calcified leaflets relative to noncalcified leaflets. 15 Although our findings have clear implications for the interpretation of VIC calcification in vitro and for the selection of biomaterials for valve regeneration, the relevance to valve calcification in vivo remains to be determined. Similar to atherosclerosis, AS is an active pathobiological process that involves extensive matrix remodeling. 5, 47, 48 The extracellular matrix provides biochemical and mechanical cues to adherent cells, and alterations in the composition 47, 49 and mechanical properties 20 of the ECM are characteristic of sclerotic diseases. The effects of matrix composition on calcification have been reported, 33, 34, 50 but the influence of matrix stiffness on vascular or valvular calcification has not been investigated. Notably, changes in the local stiffness of atherosclerotic lesions occur early, before substantial histological changes in the matrix. 20 Similar early dynamic changes in matrix mechanics are expected in sclerotic valves, but the alterations in the micromechanical stiffness of the valve matrix that occur with disease progression and the factors that contribute to these mechanical changes have yet to be determined. Although the collagen gels used here are far less complex than valve tissue in composition and structure, the modulus of the stiffer gels was comparable to that of sclerotic valve tissue (based on relative changes from normal tissue 21 ) and the modulus of the more compliant gels was approximately 2-to 3-fold greater than the micromechanical tensile modulus of normal aortic valve tissue, 51 but similar to that of early atherosclerotic lesions. 20 The matrices that mimicked the normal or early disease stiffness promoted osteogenic differentiation when the cells were exposed to calcific soluble signals, consistent with the appearance of osteoblast-like VICs early in AS 45 before the substantial matrix changes and calcification that ultimately stiffen the matrix. Although these findings are intriguing, further investigation is required to determine the role of matrix stiffness in modulating osteogenic and nonosteogenic calcification processes in vivo. In particular, translation of these findings to valve disease requires additional studies of the dynamic temporal and spatial changes that occur in matrix structure and composition during disease development and their relationships to the micromechanical properties of the valve matrix and cell phenotypes.
In summary, our data demonstrate that the differentiation of VICs and calcification in response to biochemical factors are modulated by the mechanical properties of the matrix. These data suggest an important regulatory role for matrix mechanics in valve cell biology, with implications for the interpretation of in vitro models of VIC calcification, the selection of biomaterials for tissue engineered heart valves, and possibly disease development. Although we observed that either osteogenic or myofibrogenic differentiation of VICs can result in calcification in vitro, the two processes are distinct and respectively mimic aspects of either bone formation or apoptosis-associated calcification in vivo. The identification of distinct calcification processes suggests the need for therapies that are specific, yet capable of targeting multiple pathways involved in VIC pathological differentiation and valve calcification.
